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Abstract
Background: The 2015 American Heart Association Guidelines for Cardiopulmonary Resuscitation recommend Basic
Life Support (BLS) and Advanced Life Support (ALS) rules for termination of resuscitation (TOR). However, it is
unclear whether the TOR rules are valid for out-of-hospital cardiac arrests (OHCAs) of both cardiac and non-cardiac
etiologies. In this study, we validated the TOR rules for OHCA resulting from both etiologies.
Methods: This was a prospective multicenter observational study of OHCA patients transported to 67 emergency
hospitals between January 2012 and March 2013 in the Kanto region of Japan. We calculated the specificity and
positive predictive value (PPV) for neurologically unfavorable outcomes at one month in patients with OHCA of
cardiac and non-cardiac etiologies.
Results: Of 11,505 eligible cases, 6,138 and 5,367 cases were of cardiac and non-cardiac etiology, respectively. BLS
was performed on 2,818 and 2,606 patients with OHCA of cardiac and non-cardiac etiology, respectively. ALS was
performed on 3,320 and 2,761 patients with OHCA of cardiac and non-cardiac etiology, respectively. The diagnostic
accuracy of the TOR rules for predicting unfavorable outcomes in patients with OHCA of cardiac etiology who
received BLS included a specificity of 0.985 (95 % confidence interval [CI]: 0.956–0.997) and a PPV of 0.999 (95 % CI:
0.996–1.000). In patients with OHCA from cardiac etiologies who received ALS, the TOR rules had a specificity of
0.963 (95 % CI: 0.896–0.992) and a PPV of 0.997 (95 % CI: 0.991–0.999). In patients with OHCA from non-cardiac
etiologies who received BLS, the specificity was 0.915 (95 % CI: 0.796–0.976) and PPV was 0.998 (95 % CI: 0.995–0.999).
For patients with OHCA from non-cardiac etiologies who received ALS, the specificity was 0.833 (95 % CI: 0.586–0.964)
and PPV was 0.996 (95 % CI: 0.988–0.999).
Conclusions: Both TOR rules have high specificity and PPV in patients with OHCA from cardiac etiologies. For patients
with OHCA from non-cardiac etiologies, the rules had a high PPV, but relatively low specificity. Therefore, TOR rules are
useful in patients with OHCA from cardiac etiologies, but should be applied with caution to patients with OHCA from
non-cardiac etiologies.
Keywords: Cardiopulmonary resuscitation, Decision support techniques, Emergency medical services, Out-of-hospital
cardiac arrest
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Background
Out-of-hospital cardiac arrest (OHCA) is a major public
health problem worldwide. Approximately 330,000 indi-
viduals in the United States and 275,000 individuals in
Europe experience OHCAs each year [1, 2]. The survival
rate has steadily improved in OHCA cases from cardiac
etiologies, whereas the survival rate for OHCA from
all etiologies is about 10 %, similar to the rate three
decades ago [1, 3, 4]. Most patients who survive an
OHCA are resuscitated in the prehospital setting and
are subsequently transported to emergency hospitals.
Transporting all OHCA patients to emergency hospitals
results in unnecessary consumption of valuable resources
and exposes paramedics and the public to the risks of
high-speed transportation [5].
Several studies have been conducted to prospectively
determine and test the unequivocal termination of re-
suscitation (TOR) rules. The 2015 American Heart
Association (AHA) Guidelines Update for Cardiopulmo-
nary Resuscitation and Emergency Cardiovascular Care
recommends that emergency medical service (EMS)
personnel in prehospital settings should follow TOR rules
in the protocols for basic life support (BLS) and advanced
life support (ALS) [6]. The BLS TOR rule has three cri-
teria, and all three of the following criteria must be
present before terminating BLS resuscitative attempts for
adult patients with OHCA: arrest was not witnessed by
EMS personnel; no return of spontaneous circulation
(ROSC) in the field; and no shock was delivered [7].
The ALS TOR rule recommends considering terminating
resuscitation efforts when all of the following four criteria
are met in the field: arrest was not witnessed; bystander
cardiopulmonary resuscitation (CPR) was not provided;
no ROSC after ALS care in the field; and no shock
was delivered [8].
In a prospective study, the BLS TOR rule was 100 %
predictive of death [9]. In several validation studies, both
TOR rules were reported to have a high specificity and
positive predictive value (PPV) for death or poor neuro-
logical outcomes [7, 10, 11]. The implementation of the
TOR rules significantly reduces the rate of transport of fu-
tile OHCA. However, the European Resuscitation Council
(ERC) guideline challenged the TOR rules and argued that
applying the TOR rules led to an unexpected survival of
3.4–9 % of OHCA patients without sustained ROSC in
the prehospital setting [12, 13]. Moreover, these validation
studies were performed in patients with OHCA of pre-
sumed cardiac etiology and excluded patients with
OHCA from noncardiac etiologies, such as suffocation,
pulmonary embolism, incidental hypothermia, and vascu-
lar disease [7, 9–11]. Although the TOR rules have been
validated in patients with OHCA from all etiologies in
small population studies, there have been no studies spe-
cifically focused on OHCA of noncardiac etiology [14, 15].
As a result, it remains unclear whether the TOR rules are
useful in patients with OHCA both of cardiac and noncar-
diac etiologies.
In this study, we assessed the validity of the BLS and
ALS TOR rules for patients suffering from OHCA of car-
diac or noncardiac etiology using data from the Survey of
Survivors after Cardiac Arrest, which was collected in the
Kanto Area of Japan in 2012 (SOS-KANTO 2012).
Methods
Setting and design
SOS-KANTO 2012 is a prospective, multicenter (includ-
ing 67 emergency hospitals) observational study con-
ducted between January 2012 and March 2013 in the
Kanto region of Japan. The design and data collection
methods used in SOS-KANTO 2012 have been reported
in detail in prior studies [16, 17]. The Kanto region is
made up of primarily urban areas, including Tokyo. The
institutional ethics committees of each participating in-
stitution approved the study with a waiver for informed
consent in order to protect participant anonymity.
The EMS system in Japan
The EMS system in Japan has been explained in several
previous studies [11, 18]. The EMS system is supervised
by the Fire and Disaster Management Agency of Japan
and is operated by each municipal government. All EMS
personnel are certified to perform CPR according to the
Japanese resuscitation guidelines produced by the Japan
Resuscitation Council. Generally, the ambulance crew
consists of three EMS personnel, including at least one
emergency lifesaving technician (ELST). ELSTs may per-
form several resuscitation methods under the supervi-
sion of online medical control, including the operation
of a semiautomated external defibrillator, insertion of a
supraglottic airway device, and insertion of a peripheral
intravenous line. Specially trained ELSTs have been able
to perform endotracheal intubation since 2004 and to
administer adrenaline intravenously under the supervi-
sion of online medical control since 2006. EMS
personnel in Japan are not legally permitted to terminate
resuscitation in the field, and all OHCA patients are
transported to hospitals, except in cases where death is
certain [18, 19].
Participants
All OHCA patients transported by EMS personnel to
participating institutions during the study were eligible
for inclusion in SOS-KANTO 2012. Of these patients,
the present study included only adults (18 years or
older) suffering from nontraumatic OHCA. In addition,
the following cases were excluded: cases with missing
data regarding inclusion criteria or main outcomes (e.g.,
age, etiology of cardiac arrest, outcomes 1 month after
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cardiac arrest); cases with initial resuscitation performed
inside the hospital and/or missing data for onset loca-
tion; cases in which it was unknown whether BLS or
ALS was performed by EMS personnel; and cases with
missing data regarding BLS/ALS TOR criteria. Eligible
participants were divided into two groups: those with
OHCA from cardiac etiologies, and those with OHCA
from noncardiac etiologies. Cases involving BLS and
ALS were evaluated according to the BLS and ALS TOR
rules, respectively.
Data collection and definition
The EMS personnel collected prehospital data based on
the Utstein-style template [20]. The absence of prehospi-
tal ROSC, one component of the TOR rule, was defined
as no ROSC despite resuscitation effort of the EMS
personnel until hospital arrival. Physicians collected data
regarding in-hospital treatments and outcomes, and
determined the etiology of OHCA, including cardiac
(presumed cardiac origin) and noncardiac (e.g., asphyxia,
trauma, aortic disease, drawing, cerebrovascular disease,
and drug overdose). If more than one etiology was
possible (e.g., ventricular fibrillation arrest leading to
a fall from height), the most likely primary cause was
recorded at the discretion of physicians.
Outcome measurements
The primary outcome was survival with favorable neuro-
logical outcomes 1 month after cardiac arrest, defined
as a Glasgow–Pittsburgh cerebral-performance category
of 1 (good performance) or 2 (moderate disability) on a
five-category scale [21, 22]. The other categories of 3
(severe disability), 4 (vegetative state), and 5 (death)
were defined as unfavorable neurological outcomes.
The secondary outcome was mortality 1 month after
cardiac arrest.
Statistical analysis
Descriptive statistics were calculated for all variables of
interest. Continuous variables were reported as means
and standard deviations, whereas categorical variables
were summarized using counts and percentages. The
BLS and ALS TOR rules were evaluated as diagnostic
tests. The test characteristics, including sensitivity, speci-
ficity, false-positive rate (FPR), PPV and negative predict-
ive value, were reported using 95 % confidence intervals
(CIs). Lower sensitivity meant that more patients, who
eventually died, were predicted to have good outcomes.
AHA and ERC guidelines recommend the FPR to be
close to 0 % and classify the reporting imprecision of a
diagnostic test for prognostication as serious when the
upper limit of the 95 % CI is >10 % [23, 24]. Statistical
analysis was performed using IBM SPSS for Mac Version
22.0 (IBM Corp., Armonk, NY, USA).
Results
The study flow chart is shown in Fig. 1. During the sur-
vey period, a total of 16,452 patients with OHCA were
documented. Of these, the following cases were ex-
cluded: 288 patients aged <18 years, 1075 patients with
traumatic OHCA, 494 patients with missing etiology of
arrest data, 239 cases with missing outcome data, 260
patients who initially received CPR in the hospital, and
230 cases with missing data for onset location. There-
fore, 13,866 cases of nontraumatic adult OHCA were
eligible for inclusion. However, an additional 724 cases
were excluded because it was unknown whether BLS or
ALS had been performed, and 1637 cases were ex-
cluded due to missing data regarding the TOR criteria
(12 cases, unknown witnessed events; 106 cases, un-
known shock delivery; and 1519 cases, unknown pre-
hospital ROSC). As a result, 11,505 patients were
enrolled in the present study. These patients were di-
vided into two groups, with 6138 cases of OHCA from
presumed cardiac etiologies and 5367 cases of OHCA
from noncardiac etiologies. In total, 5424 patients re-
ceived BLS (2818 cardiac cases and 2606 noncardiac
cases) and 6081 patients received ALS (3320 cardiac
cases and 2761 noncardiac cases).
The patient characteristics are presented in Table 1.
The mean patient age was 72.4 years, and 6884 patients
were men (59.8 %). Cardiac arrest occurred at home in
8395 cases (73.0 %). The mean time from call to ambu-
lance arrival on the scene was 8.0 minutes, and the mean
time from call to hospital arrival was 35.3 minutes. In
845 cases (7.3 %), the initial observed rhythm upon
arrival was ventricular fibrillation or ventricular tachy-
cardia. Advanced airways were placed in 5368 patients
(46.7 %), and adrenaline was administered to 2287 pa-
tients (19.9 %). In total, BLS was performed on 5424
patients (47.1 %) and ALS was performed on 6081
patients (52.9 %).
Regarding the TOR rules criteria, cardiac arrests
were witnessed by bystanders and EMS personnel in
5473 (47.6 %) cases and 929 (8.1 %) cases, respect-
ively. Prehospital defibrillation was delivered in 1565
cases (13.6 %), bystander-initiated CPR was performed
in 4231 cases (36.8 %), and ROSC was achieved in
the prehospital setting in 1070 cases (9.3 %). In summary,
4193 and 1701 patients met all BLS and ALS TOR criteria,
respectively.
Characteristics regarding in-hospital treatment and out-
come data are presented in Table 2. Shocks were delivered
in the emergency room in 1144 cases (9.9 %), and adren-
aline was administered in 9086 cases (79.0 %). Of the 2321
patients (20.2 %) who survived until hospital admission,
coronary angiography and therapeutic hypothermia was
performed in 520 cases (22.4 %) and 606 cases (26.1 %),
respectively. One month after admission, 11,161 cases
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(97.0 %) had unfavorable neurological outcomes, and
10,933 patients (95.0 %) had died.
Diagnostic accuracy of the TOR rules for all patients
The characteristics of the diagnostic tests for the TOR
rules for 1-month neurological outcomes and mortality
are presented in Tables 3 and 4, respectively. For all
cases (OHCA from both cardiac and noncardiac etiolo-
gies), the BLS TOR rule had a specificity of 0.971 (95 %
CI: 0.942–0.988), a FPR of 2.9 % (95 % CI: 1.2–5.8 %),
and a PPV of 0.998 (95 % CI: 0.997–0.999) for predicting
neurologically unfavorable outcomes at 1 month (Table 3).
In this same group, the BLS TOR rules had a specificity of
0.918 (95 % CI: 0.884–0.945), a FPR of 8.2 % (95 % CI:
5.5–11.6 %), and a PPV of 0.993 (95 % CI: 0.990–0.996)
for 1-month mortality (Table 4). The ALS TOR rule in pa-
tients with OHCA from both cardiac and noncardiac
etiologies had a specificity of 0.939 (95 % CI: 0.873–
0.977), a FPR of 6.1 % (95 % CI: 2.3–12.7 %), and a PPV of
0.996 (95 % CI: 0.992–0.999) for predicting neurologically
unfavorable outcomes at 1 month (Table 3). The ALS
TOR rule had a specificity of 0.913 (95 % CI: 0.869–
0.946), a FPR of 8.7 % (95 % CI: 5.4–13.1 %), and a
PPV of 0.988 (95 % CI: 0.982–0.993) for 1-month
mortality (Table 4).
Diagnostic accuracy of the TOR rules for patients with
OHCA of cardiac etiology
In patients with OHCA from cardiac etiologies, the BLS
TOR rule had a specificity of 0.985 (95 % CI: 0.956–
0.997), a FPR of 1.5 % (95 % CI: 0.3–4.4 %), and a PPV
of 0.999 (95 % CI: 0.996–1.000) for predicting neuro-
logically unfavorable outcomes at 1 month (Table 3). In
this same group, the BLS TOR rules had a specificity of
0.938 (95 % CI: 0.901–0.964), a FPR of 6.2 % (95 % CI:
3.6–9.9 %), and a PPV of 0.992 (95 % CI: 0.987–0.996)
for 1-month mortality (Table 4). The ALS TOR rule for
patients with OHCA from cardiac etiologies had a speci-
ficity of 0.963 (95 % CI: 0.896–0.992), a FPR of 3.7 %
(95 % CI: 0.8–10.4 %), and a PPV of 0.997 (95 % CI:
0.991–0.999) for predicting neurologically unfavorable
outcomes at 1 month (Table 3). For 1-month mortality,
the ALS TOR rule had a specificity of 0.941 (95 % CI:
0.891–0.973), a FPR of 5.9 % (95 % CI: 2.7–10.9 %), and
a PPV of 0.991 (95 % CI: 0.982–0.996) (Table 4).
Diagnostic accuracy of the TOR rules for patients with
OHCA of noncardiac etiology
In patients with OHCA from noncardiac etiologies, the
BLS TOR rule had a specificity of 0.915 (95 % CI:





     288 age <18 years old
  1,075 traumatic cardiac arrest
     494 unknown etiology of cardiac arrest
     260 cardiac arrests in hospital setting
     230 unknown onset location
     239 unknown outcome
13,866 adult non-traumatic OHCA
2,361 excluded
     724 missing data regarding whether BLS or ALS was performed by the EMS personnel
  1,637 missing data regarding the TOR rule criteria
           12 unknown witness
         106 unknown prehospital shock delivery
      1,519 unknown prehospital ROSC
6,138 OHCA with cardiac etiology 5,367 OHCA with non-cardiac etiology
11,505 study patients
5,424 BLS performed 3,320 ALS performed2,818 BLS performed 2,761 ALS performed2,606 BLS performed
Fig. 1 Flow diagram of the study population. The population for this study was obtained from data in the Survey of Survivors after Cardiac Arrest,
which were collected in the Kanto Area of Japan from January 2012 to March 2013. ALS advanced life support, BLS basic life support, EMS
emergency medical service, OHCA out-of-hospital cardiac arrest, ROSC return of spontaneous circulation, TOR termination of resuscitation
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Table 1 Clinical and prehospital characteristics of out-of-hospital cardiac arrest patients by group
Characteristic Total (n = 11,505) Cardiac etiology (n = 6138) Noncardiac etiology (n = 5367)
Age (years) 72.4 ± 15.8 73.4 ± 14.5 71.2 ± 17.1
Male 6884 (59.8) 3827 (62.3) 3057 (57.0)
Location of arrest
Home 8395 (73.0) 4365 (71.1) 4030 (75.1)
Public space (indoor) 352 (3.1) 217 (3.5) 135 (2.5)
Public space (outdoor) 622 (5.4) 435 (7.1) 187 (3.5)
Other 2136 (18.6) 1121 (18.3) 1015 (18.9)
EMS care interval (minutes)
Call to arrival of ambulance at scene 8.0 ± 3.6 8.0 ± 3.7 7.9 ± 3.6
Call to hospital arrival 35.3 ± 3.6 35.4 ± 11.0 35.3 ± 12.0
Initial rhythm
Ventricular fibrillation/ventricular tachycardia 845 (7.3) 752 (12.3) 93 (1.7)
Pulseless electrical activity 2369 (20.6) 1111 (18.1) 1258 (23.4)
Asystole 7550 (65.6) 3909 (63.7) 3641 (67.8)
Others or unknown 741 (6.4) 366 (6.0) 375 (7.0)
Advanced airway procedure 5368 (46.7) 2941 (47.9) 2427 (45.2)
Prehospital adrenaline administration 2287 (19.9) 1220 (19.9) 1067 (19.9)
BLS performed by EMS 5424 (47.1) 2818 (46.9) 2606 (48.6)
Met BLS TOR criteria 4193 2060 2133
ALS performed by EMS 6081 (52.9) 3320 (54.1) 2761 (51.4)
Met ALS TOR criteria 1701 956 745
Arrest witnessed by
Bystander 5473 (47.6) 2881 (46.9) 2592 (48.3)
EMS/first responder 929 (8.1) 480 (7.8) 449 (8.4)
Prehospital defibrillation (layperson and EMS) 1565 (13.6) 1249 (20.3) 316 (5.9)
Bystander-initiated CPR 4231 (36.8) 2226 (36.3) 2005 (37.4)
Prehospital ROSC 1070 (9.3) 570 (9.3) 500 (9.3)
Data presented as means ± standard deviations for continuous variables and numbers (percentage) for categorical values
ALS advanced life support, BLS basic life support, CPR cardiopulmonary resuscitation, EMS emergency medical service, ROSC return of spontaneous circulation, TOR
termination of resuscitation
Table 2 In-hospital management and 1-month outcomes for out-of-hospital cardiac arrest patients by group
Characteristic Total (n = 11,505) Cardiac etiology (n = 6138) Noncardiac etiology (n = 5367)
Defibrillation in ER 1144 (9.9) 831 (13.5) 313 (5.8)
Adrenaline administration in ER 9086 (79.0) 4819 (78.5) 4267 (79.5)
Survival until hospital admission 2321 (20.2) 1112 (18.1) 1209 (22.5)
Coronary angiographya 520 (22.4) 483 (43.4) 37 (3.1)
Therapeutic hypothermiaa 606 (26.1) 437 (39.3) 169 (14.0)
Clinical outcomes 1 month after admission
Neurologically favorable outcome (CPC 1 or 2) 344 (3.0) 279 (4.5) 65 (1.2)
Neurologically unfavorable outcome (CPC 3–5) 11,161 (97.0) 5859 (95.5) 5302 (98.8)
Survival 572 (5.0) 410 (6.7) 162 (3.0)
Death 10,933 (95.0) 5728 (93.3) 5205 (97.0)
Data presented as numbers (percentage) for categorical values
aProportion calculated using the numbers of patients who survived until hospital admission as the denominator
CPC cerebral performance category, ER emergency room
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a PPV of 0.998 (95 % CI: 0.995–0.999) for predicting
neurologically unfavorable outcomes at 1 month (Table 3).
In this same group, the BLS TOR rules had a specificity of
0.859 (95 % CI: 0.766–0.925), a FPR of 14.1 % (95 % CI:
7.5–23.4 %), and a PPV of 0.994 (95 % CI: 0.990–0.997)
for mortality at 1 month (Table 4). The ALS TOR rule for
patients with OHCA from noncardiac etiologies had a
specificity of 0.833 (95 % CI: 0.586–0.964), a FPR of
16.7 % (95 % CI: 3.6–41.4 %), and a PPV of 0.996 (95 %
CI: 0.988–0.999) for predicting neurologically unfavorable
outcomes at 1 month (Table 3). For 1-month mortality,
the ALS TOR rule had a specificity of 0.857 (95 % CI:
0.759–0.926), a FPR of 14.3 % (95 % CI: 7.4–24.1 %), and a
PPV of 0.985 (95 % CI: 0.974–0.993) (Table 4).
Characteristics of unexpected survivors with
neurologically favorable outcome
Seven and six unexpected survivors had good neurological
outcomes in the BLS and ALS TOR rules, respectively
(see Additional file 1: Table S1). Of these 13 cases, inci-
dental hypothermia, pulmonary embolism, drug overdose,
and suffocation accounted for seven cases with noncardiac
etiologies. Extracorporeal cardiopulmonary resuscitation
(ECPR) was performed in five cases.
Discussion
We investigated the diagnostic accuracy of the BLS and
ALS TOR rules for predicting unfavorable neurological
outcomes and mortality 1 month after OHCA using data
from SOS-KANTO 2012. Both TOR rules showed a high
specificity and PPV and a low FPR in patients with
OHCA of cardiac etiology. However, the TOR rules had
a high PPV but low specificity and high FPR in patients
with OHCA of noncardiac etiology. The imprecision of
the BLS and ALS TOR rules is summarized in Table 5.
For patients in the cardiac etiology group, the diagnos-
tic accuracy of the TOR rules was similar to results
reported in prior studies conducted in North America
and Japan [7, 9–11]. Similarly, the effectiveness of
both TOR rules for predicting neurologically unfavor-
able outcomes and death after OHCA in Japan was dem-
onstrated in this present study. In cases of OHCA due to
cardiac etiology, both TOR rules were useful in determin-
ing when to terminate resuscitation efforts in the prehos-
pital setting.
This study had several strengths, particularly regarding
the population and sample size. Firstly, the efficacy of
the TOR rules was validated in all patients transported
to emergency hospitals in a densely populated area of









Sensitivity (95 % CI) Specificity (95 % CI) FPR (95 % CI) PPV (95 % CI) NPV (95 % CI)
BLS TOR rule
All types
Met criteria 4186 7 0.808 0.971 2.9 % 0.998 0.193
Did not meet criteria 993 238 (0.797–0.819) (0.942–0.988) (1.2–5.8 %) (0.997–0.999) (0.172–0.217)
Cardiac etiology
Met criteria 2057 3 0.785 0.985 1.5 % 0.999 0.257
Did not meet criteria 563 195 (0.769–0.801) (0.956–0.997) (0.3–4.4 %) (0.996–1.000) (0.226–0.290)
Noncardiac etiology
Met criteria 2129 4 0.832 0.915 8.5 % 0.998 0.091
Did not meet criteria 430 43 (0.817–0.846) (0.796–0.976) (2.4–20.4 %) (0.995–0.999) (0.067–0.121)
ALS TOR rule
All types
Met criteria 1695 6 0.353 0.939 6.1 % 0.996 0.021
Did not meet criteria 4287 93 (0.341–0.365) (0.873–0.977) (2.3–12.7 %) (0.992–0.999) (0.017–0.026)
Cardiac etiology
Met criteria 953 3 0.294 0.963 3.7 % 0.997 0.033
Did not meet criteria 2286 78 (0.279–0.310) (0.896–0.992) (0.8–10.4 %) (0.991–0.999) (0.026–0.041)
Noncardiac etiology
Met criteria 742 3 0.271 0.833 16.7 % 0.996 0.007
Did not meet criteria 2001 15 (0.254–0.288) (0.586–0.964) (3.6–41.4 %) (0.988–0.999) (0.004–0.012)
ALS advanced life support, BLS basic life support, CI confidence interval, FPR false-positive rate, NPV negative predictive value, PPV positive predictive value,
TOR termination of resuscitation
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Japan. Secondly, we included almost all OHCA patients
in this area of Japan because EMS personnel in Japan
are legally obligated to transport OHCA patients to the
hospital, except in cases of obvious mortality [19, 25]. In
previous studies of this topic, TOR occurred in approxi-
mately 17 % of patients in the prehospital setting [10].
For patients in the noncardiac etiology group, the spe-
cificity of both TOR rules for neurologically unfavorable
outcomes and mortality at 1 month were relatively
low. Conversely, the PPVs of both TOR rules for pa-
tients in the noncardiac etiology group were very high
and similar to the PPVs for patients in the cardiac
etiology group. The pretest probability for 1-month
mortality and unfavorable outcomes was 97.0 % and
98.8 %, respectively; therefore a high PPV depends on
a high pretest probability.
The etiologies of cardiac arrest were categorized clinic-
ally according to the Utstein-style guidelines for cardiac
arrest data reporting [20]. Although the survival rate for
patients with OHCA of noncardiac etiology is very poor,
survival rates differ extensively for patients with OHCA
of noncardiac etiology [26]. For instance, in patients
with OHCA resulting from respiratory disease, as-
phyxia, drug overdose, and incidental hypothermia,
the survival rate is higher than in those from other
noncardiac etiologies [26]. In the present study, spe-
cial circumstances, such as incidental hypothermia or
drug overdose, were relatively common etiologies of
noncardiac unexpected survivors. The ERC guideline
also recommends that EMS personnel should consider
continuing CPR during transport to hospital in pa-
tients with OHCAs with presumed reversible causes,
Table 4 Diagnostic accuracy of termination of resuscitation rules for 1-month mortality
Etiology of cardiac arrest Deaths Survival Sensitivity (95 % CI) Specificity (95 % CI) FPR (95 % CI) PPV (95 % CI) NPV (95 % CI)
BLS TOR rule
All types
Met criteria 4165 28 0.820 0.918 8.2 % 0.993 0.255
Did not meet criteria 917 314 (0.809–0.830) (0.884–0.945) (5.5–11.6 %) (0.990–0.996) (0.231–0.280)
Cardiac etiology
Met criteria 2044 16 0.798 0.938 6.2 % 0.992 0.318
Did not meet criteria 517 241 (0.782–0.814) (0.901–0.964) (3.6–9.9 %) (0.987–0.996) (0.285–0.352)
Noncardiac etiology
Met criteria 2121 12 0.841 0.859 14.1 % 0.994 0.154
Did not meet criteria 400 73 (0.826–0.855) (0.766–0.925) (7.5–23.4 %) (0.990–0.997) (0.123–0.190)
ALS TOR rule
All types
Met criteria 1681 20 0.287 0.913 8.7 % 0.988 0.048
Did not meet criteria 4170 210 (0.276–0.299) (0.869–0.946) (5.4–13.1 %) (0.982–0.993) (0.042–0.055)
Cardiac etiology
Met criteria 947 9 0.299 0.941 5.9 % 0.991 0.061
Did not meet criteria 2220 144 (0.283–0.315) (0.891–0.973) (2.7–10.9 %) (0.982–0.996) (0.052–0.071)
Noncardiac etiology
Met criteria 734 11 0.273 0.857 14.3 % 0.985 0.033
Did not meet criteria 1950 66 (0.257–0.291) (0.759–0.926) (7.4–24.1 %) (0.974–0.993) (0.025–0.042)
ALS advanced life support, BLS basic life support, CI confidence interval, FPR false-positive rate, NPV negative predictive value, PPV positive predictive value,
TOR termination of resuscitation
Table 5 Imprecision of basic and advanced life support
termination of resuscitation rules
Etiology Imprecision
For predicting 1-month unfavorable neurological outcome
BLS TOR rule Cardiac Acceptable
Noncardiac Serious
ALS TOR rule Cardiac Serious
Noncardiac Serious
For predicting 1-month mortality
BLS TOR rule Cardiac Acceptable
Noncardiac Serious
ALS TOR rule Cardiac Serious
Noncardiac Serious
Imprecision is classified as acceptable and serious when the upper limit of the
95 % confidence interval of the false-positive rate is ≤10 % and
>10 %, respectively
ALS advanced life support, BLS basic life support, TOR termination
of resuscitation
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such as drug overdose and hypothermia [12]. More-
over, it is often difficult to determine the etiology of
cardiac arrest in the prehospital setting [27]. Cost-
effectiveness is very important in the TOR rule. Previ-
ous researchers have reported that applying the TOR
rules reduces approximately 40–50 % of futile trans-
portation and further resuscitation efforts [7, 9]. How-
ever, the decision of the TOR is more challenging in
contrast to other interventions. It has been argued
that success rates of <1 % still justify the resuscitation
effort [12]. According to our results, the TOR rules
are less useful for OHCAs of noncardiac etiology than
those of cardiac etiology. Until these discrepancies are
resolved, it would be necessary to develop new TOR
rules that are effective for OHCAs from both cardiac
and noncardiac etiologies. At the least, we consider
that the TOR rules should not be applied in cases of
presumed reversible etiologies.
According to our results, the upper limit of the FPR of
the ALS TOR rule was near 10 %, which is high for car-
diac etiology. As advanced therapies (i.e., ECPR) become
widely available, TOR rules require integration with guid-
ance on suitability for these therapies [10, 28, 29]. For
example, the low end-tidal carbon dioxide (EtCO2) value
during CPR may indicate a poor prognosis [30–32]. An
EtCO2 < 10 mmHg after 20 minutes of CPR may be con-
sidered a component of a multimodal approach to TOR,
particular for withholding ECPR [33, 34]. Although EtCO2
was not evaluated in the present study, several unexpected
survivors underwent ECPR. Therefore, consideration of
EtCO2 may improve the ALS TOR rule.
This study had several limitations. Firstly, this was
an observational study, not an interventional study.
Although prehospital TOR is not legally permitted in
Japan, resuscitation efforts might not be conducted
consistently in all OHCA patients. Secondly, SOS-KANTO
2012 was not a population-based study because it was
conducted only in the Kanto area of Japan. Therefore,
it is possible that our findings are not generalizable
to other parts of Japan or other countries. However,
the characteristics and outcomes of OHCA patients
in this study were similar to those in other population-
based studies in Japan and other countries [7, 10, 11, 18].
Finally, this study excluded pediatric patients and
those with traumatic cardiac arrest; therefore, the
effectiveness of the prehospital TOR rules for these
populations is unclear.
Conclusions
The BLS and ALS TOR rules were useful for predicting
neurologically unfavorable outcomes and mortality
1 month after the onset of OHCA of cardiac etiology.
However, these rules should be applied cautiously to pa-
tients with OHCA of noncardiac etiology.
Key messages
 The BLS and ALS TOR rules were useful for
predicting unfavorable neurological outcomes
1 month after onset of OHCA of cardiac etiology,
demonstrating both a high specificity and PPV.
 The TOR rules should be applied with caution to
patients with OHCA of noncardiac etiologies
because these rules were observed to have a high
PPV but a relatively low specificity.
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